LYSOSOMAL PROTEASES AND PROTEASE INHIBITORS IN NASAL ALLERGY AND NONATOPIC SINUSITIS

被引:13
作者
HAMAGUCHI, Y
TAYA, M
SUZUMURA, H
SAKAKURA, Y
机构
[1] Department of Otorhinolaryngology, Mie University School of Medicine, Tsu, Mie
关键词
cathepsin B; elastase; mucosal extract; nasal allergy; nasal secretion; non-atopic sinusitis;
D O I
10.1016/0196-0709(90)90168-U
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Patterns of protease activity and levels of protease inhibitors were analyzed in both nasal secretions and tissue extracts from patients with nasal allergy and non-atopic sinusitis to investigate the role of proteases in the inflammatory reaction. Protease activity was measured using specific methyl-coumaryl-7-amide substrates. The pattern of protease activity in the nasal secretions of chronic sinusitis patients was similar to that in neutrophil lysate and quite different from that in plasma. Both gluthatione activation testing and inhibition testing using synthetic inhibitors revealed that the majority of proteases in both secretions and tissues are lysosomal thiol proteases such as cathepsins B and L. Neutrophilic elastase is also a major protease in nasal secretions. In acute sinusitis, both protease activity and inhibitor levels were very high, suggesting an interaction between proteases and inhibitors. Cathepsin B and B-like thiol proteases appear to play a key role in prolonging chronic inflammation against the healing process, due to their resistance to plasma inhibitors and the shortage of thiol protease inhibitors. Protease activity in the secretions of nasal allergy patients was very weak, and the reaction between proteases and inhibitors appeared to be weak. © 1990.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 20 条
[1]  
Cardella, Davies, Allison, Immune complexes induce selective release of lysosomal hydrolases from macrophages, Nature, 247, pp. 46-48, (1974)
[2]  
Janoff, Scherer, Mediators in inflammation in leukocyte lysosomes, J Exp Med, 128, pp. 1137-1151, (1968)
[3]  
Lazarus, Brown, Daniels, Et al., Human granulocyte collagenase, Science, 159, pp. 1483-1485, (1968)
[4]  
Eriksson, Proteases and protease inhibitors in chronic obstructive lung disease, Acta Med Scand, 203, pp. 449-455, (1978)
[5]  
Kanaoka, Takahashi, Nakayama, Et al., Synthesis of a key fluorogenic amide L-arginine-4-methyl-coumaryl-7-amide (L-Arg-MCA) and its derivatives Fluorescence assays for trypsin and papain, CHEMICAL & PHARMACEUTICAL BULLETIN, 25, pp. 3126-3128, (1980)
[6]  
Kato, Adachi, Ohno, Et al., New fluorogenic peptide substrates for plasmin, J Biochem, 88, pp. 183-190, (1980)
[7]  
Morita, Kato, Iwanaga, Et al., New fluorogenic substrates for α-thrombin, factor Xa, kallikrein, and urokinase, J Biochem, 82, pp. 1495-1498, (1977)
[8]  
Kato, Adachi, Iwanaga, Et al., A new fluorogenic substrate method for the estimation of kallikrein in urine, J Biochem, 87, pp. 1127-1132, (1980)
[9]  
Mumford, Strauss, Powers, Et al., A zinc metalloendopeptidase associated with dog pancreatic membranes, J Biol Chem, 255, pp. 2227-2230, (1980)
[10]  
Hamaguchi, Ohi, Sakakura, Et al., Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation, Thromb Haemost, 54, pp. 485-489, (1985)